CAS 102767-28-2
:Levetiracetam
Description:
Levetiracetam is an antiepileptic drug primarily used to treat epilepsy and seizures. It is classified as a pyrrolidine derivative and is known for its unique mechanism of action, which involves binding to the synaptic vesicle protein 2A (SV2A), thereby modulating neurotransmitter release. Levetiracetam is characterized by its high solubility in water and moderate lipophilicity, which facilitates its absorption and distribution in the body. The compound has a molecular formula of C8H14N2O2 and a relatively low molecular weight. It is typically administered in the form of tablets, oral solution, or intravenous injection, allowing for flexible dosing options. Levetiracetam is generally well-tolerated, with a side effect profile that may include dizziness, fatigue, and behavioral changes. Importantly, it does not require routine monitoring of blood levels, making it a convenient option for many patients. Its efficacy in controlling partial-onset seizures and its favorable pharmacokinetic properties contribute to its widespread use in clinical practice.
Formula:C8H14N2O2
InChI:InChI=1S/C8H14N2O2/c1-2-6(8(9)12)10-5-3-4-7(10)11/h6H,2-5H2,1H3,(H2,9,12)/t6-/m0/s1
InChI key:InChIKey=HPHUVLMMVZITSG-LURJTMIESA-N
SMILES:[C@@H](C(N)=O)(CC)N1C(=O)CCC1
Synonyms:- (2S)-2-(2-oxopyrrolidin-1-yl)butanamide
- (S)-1-pyrrolidineacetamid
- 1-Pyrrolidineacetamide, α-ethyl-2-oxo-, (S)-
- Etiracetamum [INN-Latin]
- (S)-alpha-Ethyl-2-oxo-1-pyrrolidineacetamide
- LEVITIRACETAM
- 1-Pyrrolidineacetamide, α-ethyl-2-oxo-, (αS)-
- Keppra
- (s)-2-(2-oxopyrrolidin-1-yl)butanamide
- alpha-Ethyl-2-oxo-1-pyrrolidineacetamide
- 1-Pyrrolidineacetamide
- UCB-L 059
- Levetiracetamum [INN-Latin]
- UCB-6474
- UCB-L 059
- alpha-ethyl-2-oxo-
- Levetiracetam
- (αS)-α-Ethyl-2-oxo-1-pyrrolidineacetamide
- UCB 6474
- Name:(S)-2-(2-Oxopyrrolidin-1-yl)butanamide (Levetiracetam)
- (2R)-2-(2-oxopyrrolidin-1-yl)butanamide
- Levetiracetame
- Levetiracetam [INN]
- See more synonyms
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 23 products.
Levetiracetam
CAS:LevetiracetamFormula:C8H14N2O2Purity:100.0%Color and Shape:WhiteMolecular weight:170.10553Levetiracetam impurity standard
CAS:Levetiracetam impurity standardColor and Shape:White. To. Off-WhiteLEVETIRACETAM CRS
CAS:<p>LEVETIRACETAM CRS</p>Formula:C8H14N2O2Color and Shape:White. Powder.Molecular weight:170.209Levetiracetam
CAS:<p>Lactams, nesoi</p>Formula:C8H14N2O2Color and Shape:White PowderMolecular weight:170.10553(2S)-2-(2-oxopyrrolidin-1-yl)butanamide
CAS:Formula:C8H14N2O2Purity:98%Color and Shape:SolidMolecular weight:170.2090Levetiracetam
CAS:<p>Levetiracetam (SIB-S1) is a relatively unique anticonvulsant that is typically used in combination with other antiepileptic medications for partial onset</p>Formula:C8H14N2O2Purity:99.67% - 99.86%Color and Shape:White Crystalline PowderMolecular weight:170.21Levetiracetam
CAS:Formula:C8H14N2O2Purity:≥ 98.0% (anhydrous basis)Color and Shape:White or almost white powderMolecular weight:170.21Levetiracetam-d6 (2,3,3,4,4,4-butyramide-d6) [2(S)-(2-Oxopyrrolidin-1-yl)butyramide]
CAS:Purity:97 atom % DMolecular weight:176.25Levetiracetam
CAS:Formula:C8H14N2O2Purity:>98.0%(HPLC)(N)Color and Shape:White to Almost white powder to crystalMolecular weight:170.21Levetiracetam
CAS:<p>Applications The (S)-enantiomer of Etiracetam (E932970) and the ethyl analog of Piracetam (P500800). Used as an anticonvulsant. Neuroprotective & Neuroresearch Product.<br>References Gower, A.J., et al.: Eur. J. Pharmacol., 222, 193 (1992); Kasteleijn-Noist Trenite, D.G.A., et al.: Epilepsy Res., 25, 225 (1996); Patsalos, P.N., et al.: Pharmacol. Ther., 85, 77 (2000)<br></p>Formula:C8H14N2O2Color and Shape:NeatMolecular weight:170.21Levetiracetam
CAS:Controlled Product<p>Binds vesicle protein SV2A to alter exocytosis; anti-epileptic</p>Formula:C8H14N2O2Purity:Min. 97.5 Area-%Color and Shape:White Off-White PowderMolecular weight:170.21 g/molLevetiracetam - Bio-X ™
CAS:Controlled Product<p>Levetiracetam is a modulates the activity of the synaptic vesicle protein 2A (SV2A) in the brain and is used to treat epilepsy.It is not clear exactly how Levetiracetam affects the activity of SV2A and if this is through inhibiting the release of neurotransmitters. However, it is thought to work by binding to a specific site on SV2A, which interferes with its normal function and ultimately leads to changes in exocytosis. One of the postulated mechanisms of action is that this modulates glutamate release. Levetiracetam is used to treat certain types of seizures in people with epilepsy.<br>Levetiracetam is part of our Bio-X ™ Range. These products are aimed at life science researchers who need high quality ready-to-use products for assay development, screening or other R&D work. With a solubility datasheet and convenient vials, all of our Bio-X ™ products are in stock across our global warehouses for rapid delivery and ease of use.</p>Formula:C8H14N2O2Purity:Min. 95%Color and Shape:PowderMolecular weight:170.21 g/mol(S)-2-(2-Oxopyrrolidin-1-yl)butanamide
CAS:Formula:C8H14N2O2Purity:95.0%Color and Shape:Solid, White powderMolecular weight:170.212
![Levetiracetam-d6 (2,3,3,4,4,4-butyramide-d6) [2(S)-(2-Oxopyrrolidin-1-yl)butyramide]](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3U%2Fthumb%2FD7571.jpg&w=3840&q=75)
